PTEN and breast carcinoma: The brain-seeking subclone of the MDA-MB-231 breast cancer cell line, MDA-MB-231-BR (43) (hereafter referred to as 231-BR), has been reported to exhibit loss of PTEN expression (44) compared with parental cells.